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Abstract
The objective of the present study was to investigate nighttime activity of nonhuman primates 
during extinction and cue- and drug-primed reinstatement of methamphetamine self-
administration. Adult rhesus monkeys (Macaca mulatta; n = 5) self-administered 
methamphetamine (0.01 mg/kg/injection, i.v.) under a fixed-ratio 20 schedule of reinforcement. 
Saline infusions were then substituted for methamphetamine and stimulus light (drug-conditioned 
stimulus presented during drug self-administration) withheld until subjects reached extinction 
criteria. Drug- and cue-induced reinstatement effects were evaluated after i.v. non-contingent 
priming injections of methamphetamine (0.03, 0.1 or 0.3 mg/kg). Activity-based sleep measures 
were evaluated with Actiwatch monitors a week before (baseline nighttime activity parameters) 
and throughout the protocol. Although methamphetamine self-administration did not significantly 
affect nighttime activity compared to baseline, sleep-like parameters were improved during 
extinction compared to self-administration maintenance. Priming injection of 0.1 mg/kg 
methamphetamine, but not 0.03 or 0.3 mg/kg, induced significant reinstatement effects. These 
behavioral responses were accompanied by nighttime outcomes, with increased sleep 
fragmentation and decreased sleep efficiency in the night following 0.1 mg/kg methamphetamine-
induced reinstatement. In the absence of both drug and drug-paired cues (extinction conditions), 
nighttime activity decreased compared to self-administration maintenance. Additionally, effective 
reinstatement conditions impaired sleep-like measures. Our data indicate that the reintroduction of 
the stimulus light as a drug-paired cue increased nighttime activity.
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Introduction
Drug addiction is a chronic and relapsing disorder. Thus, relapse is a major problem in drug 
abuse, and understanding factors that might contribute or lead to relapse is mandatory in 
addiction research. During drug use, contextual cues where the drug is being experienced 
become associated with the drug effects (Kalivas, 2002). Drug-associated cues are able to 
induce relapse per se (Weiss, 2005), posing drug-environment conditioning as one of the 
biggest challenges in addiction treatment.
Sleep impairment also enhances the risk of relapse (Brower & Perron, 2010). Of note, 
individuals in rehabilitation from abuse of any kind of addictive substance show sleep 
disturbances (Brower & Perron, 2010). We have previously demonstrated that 
methamphetamine self-administration disrupts actigraphy-based sleep-like measures in 
rhesus monkeys, although nighttime activity was restored during subsequent periods of drug 
abstinence (Andersen et al., 2013).
No study to date has evaluated sleep patterns during the extinction and cue- and drug-
induced reinstatement of methamphetamine-seeking behavior. Because the effects of sleep 
on substance abuse seem to be mediated by the conditioned element of addiction (Berro et 
al., 2014; Frussa-Filho et al., 2004) and both sleep and conditioning seem to influence 
relapse, this investigation is of major significance.
Accordingly, the aim of the present study was to investigate the sleep-like measures 
generated by nighttime activity data of nonhuman primates during extinction and cue- and 
drug-primed reinstatement of methamphetamine self-administration.
Methods
Subjects
Three male and 2 female adult rhesus monkeys (Macaca mulatta), weighing 9–17kg, served 
as subjects. Each subject was individually housed in stainless steel home cages and fed 
Purina monkey chow (Ralston Purina, St. Louis, MO), supplemented with fruit and 
vegetables. Water was continuously available in the colony. The colony was maintained at 
an ambient temperature of 22±2°C at 45–50% humidity, and the lights were set to a 12-h 
light/dark cycle (lights on at hour 07:00; lights off at hour 19:00). Environmental enrichment 
was provided on a regular, rotating basis. All procedures followed the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals (Publication No.85-23, revised 
1985), and were approved by the Institutional Animal Care and Use Committee of Emory 
University. Animals were fitted with collars (Primate Products) prior to the initiation of the 
studies. All subjects had a previous history of methamphetamine self-administration.
Drugs
Methamphetamine HCl was provided by the National Institute on Drug Abuse (Research 
Technology Branch, Research Triangle Park, N.C., USA), and was dissolved in sterile 
physiological saline. The drug dose was determined as the salt.
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Self-administration
All animals were surgically prepared with a chronic indwelling venous catheter under sterile 
conditions. The apparatus and self-administration procedure were described in detail by 
Howell and Wilcox (2001). Animals were previously trained to respond under a fixed-ratio 
(FR) 20 schedule of drug delivery. Subjects had the opportunity to self-administer 
methamphetamine during 60-min sessions once a day, 7 days/week in the morning (starting 
between 7–9 am). Animals were placed in a primate chair (Primate Products) and placed in a 
sound-attenuating experimental chamber for the duration of the session. The rest of the day, 
animals were maintained in their home-cages. Each session began with a 5 min start delay, 
after which the initiation of the schedule contingencies, including the availability of 
methamphetamine, was signaled by the illumination of a white light (discriminative 
stimulus). Completion of the FR 20 response requirement resulted in a change in the 
stimulus light from white to red (conditioned reinforcement) for 15s and a 
methamphetamine infusion (0.01 mg/kg in 0.5 ml). Following each methamphetamine 
delivery, a 1 min timeout period was initiated wherein all lights were extinguished and 
responding had no programmed consequences.
Extinction
During extinction sessions, the behavioral chamber was illuminated with the white light 
discriminative stimulus. Upon completion of the FR 20 response requirement, the red 
stimulus light was withheld and animals received a saline infusion.
Reinstatement
The reinstatement test day consisted of an experimenter-administered prime of 
methamphetamine given through the vascular access port immediately before the onset of 
the session. Completion of the response requirement resulted in the intravenous delivery of 
saline and the illumination of the conditioned reinforcer over 15s. Therefore, we describe the 
sessions as drug- and cue-induced reinstatement tests. Reinstatement effects were 
determined across a range of methamphetamine priming doses (0.03, 0.1, or 0.3 mg/kg, i.v.) 
in a randomized order.
Nighttime Activity
Actiwatch sensors (Mini Mitter, Bend, OR, USA) were used to assess nighttime activity in 
the subjects, as previously described (Andersen et al., 2010, 2013). Subjects were previously 
trained to cooperate with the attachment of the Actiwatch sensor in their collars. The 
nighttime activity data obtained from the Actiwatch devices generate the following sleep-
like behavior parameters: sleep efficiency (i.e., the percentage of the dark phase spent 
sleeping); fragmentation index (immobile bouts during the dark phase that lasted less than 1 
minute during the sleep recording period). All parameters were calculated using the 
Actiware software program.
Protocol Design
The Actiwatch was attached to the monkeys’ collars while in the primate chair 1 week 
before the beginning of methamphetamine self-administration and spontaneous baseline 
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nighttime activity was measured for 5 days. During baseline condition, animals were kept 
undisturbed in their home-cages. After subjects underwent self-administration sessions for 5 
days, extinction sessions began. Behavior was considered extinguished when response rates 
over 2 sequential sessions were <20% of the last 3 days mean rate during maintenance of 
methamphetamine self-administration. Starting on the day after subjects reached extinction 
criteria, the 3 reinstatement sessions were conducted with 1 no-drug day between sessions.
Statistical Analysis
Behavioral data and sleep parameters were analyzed using one-way repeated-measures 
ANOVA followed by Bonferroni’s post-hoc test. Correlational analyses were conducted 
using Pearson’s Correlation. Significance was accepted at an alpha of 0.05.
Results
Behavioral Data
Methamphetamine reliably maintained self-administration in all 5 subjects, with average 
drug intake ranging from 0.23 to 0.44 mg/kg/session. During extinction, response rates 
typically declined within two of sessions from ~0.6 to ~0.05 responses/s. For the 
reinstatement sessions, one-way repeated measures ANOVA revealed a significant main 
effect of the priming dose [F(3,12)=22.07, p<0.001]. Bonferroni’s post-hoc test identified 
that a priming injection of 0.1 mg/kg methamphetamine, but not 0.03 or 0.3 mg/kg, 
significantly reinstated operant behavior compared with extinction (p<0.05, Figure 1). The 
priming dose of 0.1 mg/kg engendered response rates which were ~50% of the rates 
typically observed during methamphetamine self-administration.
Nighttime Activity
Figure 2 shows sleep-like behavior parameters across the different experimental periods. 
Data for baseline sleep and self-administration maintenance are combined across a 5-day 
span of time. Sleep-like parameters are presented as normalized data (percentage of 
baseline). Individual-subject baseline data are presented on Table 1. In general, the 2 female 
rhesus macaques presented higher nighttime activity (lower sleep efficiency and higher sleep 
fragmentation) than the 3 males on baseline conditions. Although the sample size is 
inadequate to statistically examine these differences, it demonstrates marked individual 
subject differences with respect to activity-based sleep measures, what might account for the 
results obtained. One-way repeated measures ANOVA revealed a significant difference 
across experimental conditions for both sleep efficiency [F(5,20)=11.39; p<0.001] and sleep 
fragmentation [F(5,20)=7.26; p<0.01]. Bonferroni’s post-hoc test indicated that 
methamphetamine self-administration did not significantly affect nighttime activity 
compared to baseline. However, nighttime activity was significantly lower during extinction 
compared to self-administration maintenance (increased sleep efficiency in ~28%, p<0.05; 
decreased sleep fragmentation in ~26%, p<0.01). For reinstatement, sleep-like behavior was 
significantly impaired in the night following 0.1 mg/kg, but not 0.03 or 0.3 mg/kg, 
methamphetamine-induced reinstatement compared to extinction (decreased sleep efficiency 
in ~21%, p<0.05; increased sleep fragmentation in ~31%, p<0.05).
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Correlation: Behavioral data vs Nighttime Activity
Pearson’s Correlation analysis indicated a significant correlation between methamphetamine 
intake during active self-administration and sleep fragmentation [r=0.93, p<0.01], but not 
sleep efficiency [r=0.42, p>0.05] (Figure 3). Individual variability with respect to activity-
based sleep measures, as observed in Table 1, might contribute to the absence of difference 
in nighttime activity between baseline and active self-administration conditions, and the 
presence of a positive correlation between sleep fragmentation and methamphetamine intake 
during active self-administration.
Additional analysis also indicated that nighttime activity measures after effective 
reinstatement conditions (night following 0.1 mg/kg methamphetamine-induced 
reinstatement) did not significantly correlate with response rates during the respective 
reinstatement session (sleep efficiency [r=−0.12, p>0.05]; sleep fragmentation [r=0.15, 
p>0.05])(Figure 4).
Discussion
We evaluated nighttime activity of rhesus monkeys on baseline (no-drug) condition and on 
the night after methamphetamine self-administration, extinction and cue- plus 
methamphetamine-induced reinstatement sessions. At the dose used in the present study, 
methamphetamine self-administration did not significantly affect nighttime activity 
compared to baseline. However, methamphetamine intake was positively correlated with 
sleep fragmentation. Sleep-like parameters were improved during extinction compared to 
self-administration maintenance. Also, priming injection of 0.1 mg/kg methamphetamine, 
but not 0.03 or 0.3 mg/kg, induced significant reinstatement effects. These behavioral 
responses were accompanied by nighttime outcomes, with increased sleep fragmentation and 
decreased sleep efficiency in the night following 0.1 mg/kg methamphetamine-induced 
reinstatement.
Because an increase in nighttime activity during reinstatement was not a monotonic function 
of drug dose, the direct pharmacological effects of the priming injection on sleep parameters 
are unlikely to account for the results obtained. Rather, reinstatement effects observed in the 
present study were bi-phasic (i.e., highest dose of methamphetamine did not induce effective 
reinstatement). Average drug intake ranged from 0.23 to 0.44 mg/kg/session during active 
methamphetamine self-administration sessions, without inducing changes in nighttime 
activity. In a previous study from our group, average drug intake ranged from 0.09 to 0.33 
mg/kg/session when methamphetamine self-administration sessions were conducted with the 
unit dose of 0.01 mg/kg/infusion (Andersen et al., 2013). Under these conditions, there was 
no significant effect on nighttime activity. Of importance, when the unit dose of 
methamphetamine during self-administration sessions was increased to 0.03 mg/kg/infusion, 
with drug intake increasing to 0.22–0.996 mg/kg/session, a marked increase in nighttime 
activity was observed. Thus, methamphetamine effects on nighttime activity are dose-
dependent without evidence of a bi-phasic function.
Except for the drug priming, the main difference between extinction and effective 
reinstatement sessions was the presentation or not of the drug-conditioned stimulus (red 
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light). Thus, it appears that the presence or absence of conditioned stimuli mediated sleep-
like behavior outcomes observed following extinction and reinstatement sessions. In the 
absence of both drug and drug-paired cues (extinction conditions), there was a decrease in 
nighttime activity compared to self-administration maintenance. Additionally, effective 
reinstatement conditions impaired sleep-like measures compared to the night after effective 
extinction conditions. We hypothesize that the reintroduction of the stimulus light as a drug-
paired cue increased nighttime activity. Corroborating our hypothesis, nighttime activity was 
also lower after extinction compared to the night following methamphetamine self-
administration sessions, during which drug-paired stimulus also occurred.
Response rates during effective reinstatement sessions did not correlate with nighttime 
activity parameters in the following night. Because response rates under a FR schedule of 
reinforcement directly reflect the presentation of the stimulus light during the session, this 
analysis suggests that the presentation of the conditioned stimulus light might be important 
but not sufficient to explain an improved nighttime activity after effective reinstatement 
conditions. Therefore, although our data support the hypothesis proposed herein, additional 
tests could be informative in order to validate this hypothesis, such as the investigation of 
drug- or cue-induced reinstatement on nighttime activity separately.
Our data are consistent with previous studies suggesting that sleep loss exerts its effects on 
psychostimulant addiction through manipulations in the conditioned component of substance 
abuse. In rodents, sleep deprivation specifically potentiates context-dependent 
amphetamine-induced behavioral sensitization (Frussa-Filho et al., 2004) and impairs the 
extinction of cocaine-induced environmental conditioning (Berro et al., 2014). Our results 
further indicate that the repeated introduction of drug-paired stimuli is sufficient to induce 
sleep disruption, inducing an alarming cycle that might ultimately contribute to the 
continuation of drug abuse.
In summary, we provide evidence that drug-seeking behavior culminating in the 
presentation of drug-paired stimuli has a negative impact on sleep. Because drug-
environment conditioning plays a key role in the addictive cycle (Kalivas, 2002) and sleep 
impairment is considered a risk factor for drug relapse (Brower & Perron, 2010), sleep 
patterns must be considered in treatment strategies. A preserved sleep architecture during 
abstinence periods and after relapse could facilitate the rehabilitation process.
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Figure 1. 
Response rates during extinction and reinstatement after priming injections of 
methamphetamine (METH, 0.03, 0.1 or 0.3 mg/kg, IV). Data points represent mean±SEM. 
*p<0.05 compared to Extinction(Saline); Δ p<0.05 compared to 0.1 METH Reinstatement. 
One-way repeated measures ANOVA followed by Bonferroni’s post-hoc test.
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Figure 2. 
(A) Sleep efficiency and (B) sleep fragmentation at baseline, methamphetamine self-
administration maintenance (0.01 mg/kg/infusion), extinction, or reinstatement test sessions 
conducted with three different doses of methamphetamine (METH, 0.03, 0.1 or 0.3 mg/kg, 
IV). Nighttime activity data for baseline and self-administration maintenance were 
combined across a 5-day span of time. Nighttime activity data for extinction were recorded 
as the night after the first effective extinction session. Data are expressed as mean±SEM. 
*p<0.05 compared to Maintenance (0.01 METH); Δ p<0.05 compared to Extinction(Saline). 
One-way repeated measures ANOVA followed by Bonferroni’s post-hoc test.
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Figure 3. 
Correlation between methamphetamine intake (0.01 mg/kg/injection self-administration) 
and sleep (A) efficiency or (B) fragmentation following self-administration days. Pearson‘s 
Correlation.
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Figure 4. 
Correlation between response rates and sleep (A) efficiency or (B) fragmentation following 
effective reinstatement conditions (reinstatement effects induced by priming injection of 0.1 
mg/kg methamphetamine). Pearson‘s Correlation.
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Table 1
Individual-subject baseline sleep parameters
Subject Sleep Efficiency (%) Fragmentation Index
ROf8 (M) 83.1 ± 0.74 24.86 ± 0.87
RVm8 (F) 64.28 ± 4.46 71.13 ± 2.76
RLk4 (M) 68.83 ± 1.74 50.75 ± 3.04
RZs9 (F) 34.42 ± 2.38 88.22 ± 4.26
RJl8 (M) 86.21 ± 0.56 30.95 ± 2.45
M = male rhesus monkey; F = female rhesus monkey. Data are expressed as mean±SEM.
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